White Paper

Sensitive detection of BRAF gene mutation is key to a cure

May 26, 2015

With medical advancements being made in the treatment of metastatic melanoma, Bioron Diagnostics has come up with a system that enables the robust sensitive detection of mutations at the BRAF gene associated with sensitivity of melanoma cells to inhibitors of the BRAF kinase. Such breakthroughs could help to significantly increase the survival rates of cancer patients by allowing the use of efficient target therapy.

Download to find out more.